EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic exploration and in silico prioritization of putative COX-2-targeting metabolites from Streptomyces sp. VITGV156 (MCC 4965)

Veilumuthu Pattapulavar, Saranyadevi Subburaj, Sathiyabama Ramanujam, Priyadharshini Suresh Babu, Krishna Santhoshkumar, Anitha Kandasamy, Ramasamy Tamizhselvi, Divya Sharma, John Godwin Christopher

Frontiers in Bioinformatics · 18.08.2026 · 6

DOI: 10.3389/fbinf.2026.1840680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioinformatics, online erschienen am 18.08.2026. Verfasst von Veilumuthu Pattapulavar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of BioMedical Sciences, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Streptomyces species represent an important source of bioactive natural products, yet systematic genome-guided prioritization of metabolites targeting cyclooxygenase-2 (COX-2/PTGS2) remains limited. This study aimed to investigate the biosynthetic potential of Streptomyces sp. VITGV156 (MCC 4965) using an integrated genome mining and computational drug discovery pipeline.

Methods

Whole-genome sequencing, functional annotation, antiSMASH v7.0.1-based biosynthetic gene cluster (BGC) prediction, LC-MS/MS metabolomic profiling, SwissADME analysis, target prediction, disease association mapping, molecular docking against PTGS2 (PDB: 5IKR), and PASS bioactivity prediction were performed to prioritize putative bioactive metabolites.

Results

Genome analysis identified 29 predicted biosynthetic gene clusters, including clusters associated with geosmin, ectoine, albaflavenone, hopene, coelichelin, and SapB, together with several cryptic clusters exhibiting low similarity to known pathways. LC-MS/MS metabolomic profiling provided experimental support for active secondary metabolite production under the cultivation conditions employed. Computational prioritization identified PTGS2 (COX-2) as a biologically relevant target. Molecular docking demonstrated favorable binding affinities and interaction profiles for several predicted metabolites within the PTGS2 catalytic pocket. PASS analysis further suggested potential anticancer-related biological activities that require experimental validation.

Discussion

These findings demonstrate the utility of integrating genome mining, metabolomic profiling, and computational drug discovery for prioritizing natural-product candidates. Streptomyces sp. VITGV156 (MCC 4965) represents a promising source of biosynthetic diversity and provides a genome-guided framework for identifying putative COX-2-targeting natural products for future experimental validation rather than confirming metabolite production or biological activity.

Schlagwörter

Stichwörter der Autor:innen

COX-2 (PTGS2)biosynthetic gene clustersgenome miningin silico drug discoverymetabolomic profilingnatural product prioritizationputative anticancer metabolitesstreptomyces sp. VITGV156 (MCC 4965)

Autor:innen und Institutionen

  • Department of BioMedical Sciences, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India.
  • Department of Biotechnology, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India.
  • Department of Physics, School of Physics, Madurai Kamaraj University, Madurai, Tamil Nadu, India.
  • Department of Biosciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Zitieren

APA

Pattapulavar, V., Subburaj, S., Ramanujam, S., Babu, P. S., Santhoshkumar, K., Kandasamy, A., Tamizhselvi, R., Sharma, D., & Christopher, J. G. (2026). Genomic exploration and in silico prioritization of putative COX-2-targeting metabolites from Streptomyces sp. VITGV156 (MCC 4965). Frontiers in Bioinformatics, 6. https://doi.org/10.3389/fbinf.2026.1840680

Vancouver

Pattapulavar V, Subburaj S, Ramanujam S, Babu PS, Santhoshkumar K, Kandasamy A, et al. Genomic exploration and in silico prioritization of putative COX-2-targeting metabolites from Streptomyces sp. VITGV156 (MCC 4965). Frontiers in Bioinformatics. 2026;6. doi:10.3389/fbinf.2026.1840680

BibTeX
@article{Pattapulavar2026,
  author = {Pattapulavar, Veilumuthu and Subburaj, Saranyadevi and Ramanujam, Sathiyabama and Babu, Priyadharshini Suresh and Santhoshkumar, Krishna and Kandasamy, Anitha and Tamizhselvi, Ramasamy and Sharma, Divya and Christopher, John Godwin},
  title = {Genomic exploration and in silico prioritization of putative COX-2-targeting metabolites from Streptomyces sp. VITGV156 (MCC 4965)},
  journal = {Frontiers in Bioinformatics},
  year = {2026},
  volume = {6},
  doi = {10.3389/fbinf.2026.1840680}
}
Kostenlos starten →